BioRestorative Therapies, Inc. (BRTX)
1.91
+0.02
(+1.06%)
USD |
NASDAQ |
Oct 09, 16:00
1.86
-0.05
(-2.62%)
After-Hours: 20:00
BioRestorative Therapies Cash from Operations (Quarterly) : -3.808M for March 31, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -3.808M |
| December 31, 2025 | -2.415M |
| September 30, 2025 | -2.901M |
| June 30, 2025 | -2.694M |
| March 31, 2025 | -2.779M |
| December 31, 2024 | -2.348M |
| September 30, 2024 | -1.700M |
| June 30, 2024 | -1.865M |
| March 31, 2024 | -2.318M |
| December 31, 2023 | -1.588M |
| September 30, 2023 | -1.179M |
| June 30, 2023 | -1.284M |
| March 31, 2023 | -2.379M |
| December 31, 2022 | -1.573M |
| September 30, 2022 | -1.452M |
| June 30, 2022 | -1.251M |
| March 31, 2022 | -1.595M |
| December 31, 2021 | -1.145M |
| September 30, 2021 | -0.6294M |
| June 30, 2021 | -0.7418M |
| March 31, 2021 | -0.8137M |
| December 31, 2020 | -0.5721M |
| September 30, 2020 | -0.5231M |
| June 30, 2020 | -0.4204M |
| March 31, 2020 | -0.4486M |
| Date | Value |
|---|---|
| December 31, 2019 | -1.811M |
| September 30, 2019 | -1.711M |
| June 30, 2019 | -1.417M |
| March 31, 2019 | -1.980M |
| December 31, 2018 | -1.553M |
| September 30, 2018 | -1.353M |
| June 30, 2018 | -1.040M |
| March 31, 2018 | -1.158M |
| December 31, 2017 | -1.360M |
| September 30, 2017 | -0.5092M |
| June 30, 2017 | -0.766M |
| March 31, 2017 | -1.219M |
| December 31, 2016 | -1.062M |
| September 30, 2016 | -1.206M |
| June 30, 2016 | -1.018M |
| March 31, 2016 | -1.718M |
| December 31, 2015 | -1.054M |
| September 30, 2015 | -0.5836M |
| June 30, 2015 | -0.8096M |
| March 31, 2015 | -0.6748M |
| December 31, 2014 | -0.6343M |
| September 30, 2014 | -0.8337M |
| June 30, 2014 | -0.9532M |
| March 31, 2014 | -0.8067M |
| December 31, 2013 | -0.7638M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -8.30M |
| CareDx, Inc. | 30.60M |
| Natera, Inc. | 54.79M |
| Exagen, Inc. | 3.988M |
| Sera Prognostics, Inc. | -6.311M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.9684M |
| Cash from Financing (Quarterly) | 4.441M |
| Free Cash Flow | -11.90M |
| Free Cash Flow Per Share (Quarterly) | -4.296 |
| Free Cash Flow to Equity (Quarterly) | -3.699M |
| Free Cash Flow to Firm (Quarterly) | -3.808M |
| Free Cash Flow Yield | -1.12K% |